02/07/2026
A new review by the Vaccine Integrity Project of the Center for Infectious Disease Research and Policy confirms that there is no benefit of delaying the hepatitis B vaccine birth dose. The report also shows significant reduction in infections for those vaccinated.
Researchers state that recent changes to U.S. vaccine policies were not supported by any analysis on the possible risks of delaying hepatitis B vaccination. Decades of evidence have shown the hepatitis B vaccine is critical for helping to protect children from developing chronic hepatitis B.